Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Evaluation of Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorders

NCT03230006 is registered in ClinicalTrials.gov with Boston University Charles River Campus as lead sponsor.

NCT NCT03230006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03230006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Evaluation of Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorders
Lead sponsor
Boston University Charles River Campus
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2018
Completion date
January 31, 2024
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, anxiety disorders